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strates. The 0-phosphate was readily de-
conjugated by all acid and alkaline phos-
phatases tested but no evidence was obtained
for cleavage of the 0-sulphate by limpet or
rat liver microsomal or lysosomal sulphatases.
The 0-glucuronide was a good substrate for
mammalian liver lysosomal glucuronidases.
These results appear to eliminate the 0-
sulphate as a suitable drug for enzyme
activation but substantiate the possible
usefulness of the 0-phosphate and 0-
glucuronide.
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IN VITRO EFFECTS OF ICRF 159. K.
HELLMANN and R. C. HALLOWES. Depart-
ments of Cancer Chemotherapy and Patho-
logy, Imperial Cancer Research Fund,
London.
The effects of ICRF 159 were studied on
transformed hamster cells in culture. 5 cm
dishes were each plated with 104 cells and
cultured at 37°C for up to 72 hours in Eagle's
medium containing a range of concentrations
ofICRF 159. The cells were either harvested
at the completion of the culture period or
were transferred to drug-free medium.
Cell numbers increased to 2*5 x 104
during the first 24 hours invarious concentra-
tions of ICRF 159 up to 20 ,tg/ml, but the
rate of increase diminished with increasing
drug concentrations during the next 48 hours.
The rate of increase returned towards control
values when cells were transferred to drug-
free medium, provided the change occurred
before 72 hours and only in drug concentra-
tions of less than 10 tug/ml.
Specific morphological changes occurred
in cells exposed to the drug which may enable
the site ofaction ofthe drug to be determined.
EFFECTS OF THE ANTICOAGULANT,
DEGRADED CARRAGEENAN, ON
EXPERIMENTAL TUMOUR GROWTH.
B. JOLLES, R. G. HARRISON and E. A.
MOORE. Cancer and Radiobiology Research
Laboratories, General Hospital, North-
ampton.
As the survival ofan experimental tumour
graft depends largely on the formation by the
host ofa newtumour stroma toreplace thatof
the graft which is absorbed within 48-72
hours of implant, the study of substances
with " anticoagulant " and fibrinolytic pro-
perties is of importance (O'Meara, Irish J.
med. Sci., 1958, 474; Jolles, Lancet, 1963,
iii, 1234).
In previous work, the effects of inter-
ference with some fundamental events in
connective tissue by heparin (Jolles and
Greening, Acta Un. int. Cancer., 1960, 16,
682) and of laminarin, a mucopolysaccharide
derived from the seaweed Laminaria cloustoni
(Jolles, Remington and Andrews, Br. J.
Canicer, 1963, 17, 109) have been shown to
reduce the rate of growth of Sarcoma S.180 in
mice.
In the present series, in which the design
of the experiments was along the same lines
as those followed in the heparin andlaminarin
studies, a degraded Carrageenan derived
from red seaweeds injected subcutaneously
(0 05 ml in a 1-0, 1-5 or 2% concentration)
3 times weekly for 2 weeks, or twice weekly
for 4 weeks at a site adjacent to the implanted
tumour or intraperitoneally (0-1 ml/animal)
reduces the rate of tumour growth.
PROLACTIN AND BREAST CANCER.
P. G. SALUJA, J. M. HAMILTON and M.
GRONOW. Department of Experimental
Pathology and Cancer Research, University
of Leeds.
Although prolactin is of supreme impor-
tance in the aetiology and genesis of rodent
mammary tumours (Muhlbock and Boot,
Cancer Res., 1959, 19, 402; Pearson et al.,
Trans. Ass. Am. Physns, 1969, 82, 225), it is
not known whether it is implicated in mam-
mary carcinogenesis in other species. In
view of the many similarities that exist
between human and canine breast cancer
(Misdorp, 1964, Thesis, Utrecht; Schneider,
Cancer, N. Y., 1970, 26, 419), an investigation
was carried out ofthe prolactin concentration
in the adenohypophysis of dogs afflicted with
breast tumours.
Baseline values were established for
normal dogs in which pituitary prolactin
concentration was found to vary according to
reproductive state (e.g. low in dioestrus,
high in lactation). In bitches with mam-
mary carcinoma, prolactin levels were signifi-
cantly higher than in normal subjects of com-
parable endocrine state. This finding indi-
cates that prolactin imbalance may be
involved in canine mammary neoplasia.